低分化肺外神经内分泌癌患者[68Ga]Ga-DOTATATE PET生长抑素受体表达的前瞻性研究
该前瞻性研究纳入30例转移性肺外神经内分泌癌(NEC)患者,比较[68Ga]Ga-DOTATATE PET与[18F]FDG PET,主要终点为肿瘤均匀[68Ga]Ga-DOTATATE摄取(高于正常肝)的患者比例。结果显示仅4例(13%)呈现均匀强摄取(Krenning 3或4级),表明在未选择的肺外NEC患者中,均匀强SSTR表达相对少见。
要点
- 转移性肺外NEC中仅13%患者[68Ga]Ga-DOTATATE PET呈均匀强SSTR表达。
- 既往回顾性报道高达40%的强SSTR表达可能受选择偏倚影响。
- 前瞻性设计比较[68Ga]Ga-DOTATATE与[18F]FDG PET,支持SSTR表达不普遍。
核心结论
- 在未选择的转移性肺外NEC患者中,均匀强SSTR表达相对少见,仅13%患者显示Krenning 3或4级摄取。
研究设计与样本
- 前瞻性研究纳入30例转移性肺外NEC患者,均行[68Ga]Ga-DOTATATE PET,其中28例在预设2个月内行[18F]FDG PET。
- 原发部位包括胰腺7例、结直肠6例、子宫2例,原发灶不明9例;组织学亚型包括小细胞15例、大细胞6例、混合或未分型9例。
- 主要终点为肿瘤均匀[68Ga]Ga-DOTATATE摄取(高于正常肝)的患者比例,次要终点为无SSTR表达或异质性表达的患者比例。
主要发现
- 仅4例患者(13%)在[68Ga]Ga-DOTATATE PET上显示均匀强摄取(Krenning 3或4级),表明强SSTR表达。
- 所有患者横断面影像均有可测量转移灶,部分病例[18F]FDG PET代谢摄取可能因既往化疗而减弱。
关键数值与推荐
- 均匀强SSTR表达定义为[68Ga]Ga-DOTATATE摄取高于正常肝且Krenning分级为3或4级,仅4例(13%)符合。
临床怎么用
- 对转移性肺外NEC患者,不应常规假设存在强SSTR表达,[68Ga]Ga-DOTATATE PET可用于评估SSTR状态以指导治疗决策。
局限性
- 样本量较小(30例),部分患者[18F]FDG PET代谢摄取可能受既往化疗影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Limited data are available regarding somatostatin receptor (SSTR) expression in poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). Some retrospective series have reported strong SSTR expression in up to 40% of patients with NEC. However, these figures may be influenced by selection bias, such as imaging of patients with lower Ki-67 index or uncertainty about pathologic tumor differentiation. Methods: In this prospective study, [68Ga]Ga-DOTATATE PET was compared with [18F]FDG PET in patients with metastatic extrapulmonary NEC and at least 1 measurable site of metastasis. The primary endpoint was the proportion of patients with tumors showing uniform [68Ga]Ga-DOTATATE avidity (uptake greater than that in the normal liver). The secondary endpoint was the proportion of patients with no SSTR expression or a heterogeneous pattern of expression. Results: This study enrolled 30 patients who underwent [68Ga]Ga-DOTATATE PET, 28 of whom also underwent [18F]FDG PET within a prespecified 2-mo interval from [68Ga]Ga-DOTATATE PET. Primary tumor sites included the pancreas (n = 7), colon/rectum (n = 6), and uterus (n = 2); the sites of 9 primary tumors were unknown. Histologic subtypes included small cell (n = 15), large cell (n = 6), and mixed or unspecified types (n = 9). All patients had radiographically measurable metastases on cross-sectional imaging, although metabolic uptake on [18F]FDG PET may have been attenuated by prior chemotherapy administration in some cases. Only 4 patients (13%) had evidence of uniformly avid uptake (Krenning grade 3 or 4) on [68Ga]Ga-DOTATATE PET, indicating strong SSTR expression. Conclusion: Avid, uniform SSTR expression was relatively uncommon in unselected patients with extrapulmonary NEC.
引用
- Strosberg JR, Al-Toubah T, Haider M, et al. Somatostatin Receptor Expression on [68Ga]Ga-DOTATATE PET Among Patients with Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas: A Prospective Study. J Nucl Med. 2026. PMID: 42276784. doi:10.2967/jnumed.125.271460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。